Patent Law Updates | New Statutes, Regulations and Rules

January 4, 2012

USPTO Seeks Comments on Future Locations for Satellite Offices

Request for Comments on Additional USPTO Satellite Offices for the Nationwide Workforce Program
USPTO No. 11-69, FR Doc No: 2011-30717, Docket No. PTO-C-2011-0066, 11/29/2011

USPTO Seeks Comments on Future Locations for Satellite Offices

The United States Patent and Trademark Office (USPTO) has released a Federal Register Notice seeking written comments on potential additional locations for USPTO satellite offices.

“Establishing satellite offices in geographically diverse areas of the country will allow the agency to better recruit and retain talented patent professionals and allow the agency to better interact with the applicant community,” said Under Secretary of Commerce for Intellectual Property and Director of the USPTO David Kappos. “We are committed to conducting a transparent selection process based on objective criteria, and with input from stakeholders around the country.”

An initial USPTO satellite office is already planned to be established in Detroit, Michigan.  The agency plans to open its Detroit facility in the second half of 2012.  The Detroit satellite office is expected to create more than 100 high-paying, high-skill jobs in its first year of operation and represents the first phase of the USPTO’s satellite office project, an effort to hire more patent examiners and seek out additional technical expertise in locations across the country.

In choosing Detroit, the USPTO considered multiple cities and sought a location where the agency could best recruit and retain patent examiners and increase applicant outreach.  The criteria included, but was not limited to: occupational clusters; number of patent attorneys and agents currently in the region; number of patent applications by state; access to universities with strong engineering programs; public transportation infrastructure and proximate location to a major airport; the ability to share facilities with other established governmental operations; the ability to support departmental objectives, including CommerceConnect, and increase collaborations among Commerce bureaus; and various economic factors, including cost of living and unemployment rates of the city.

Subject to available resources and as provided for in the America Invents Act, the USPTO intends to establish at least two more satellite offices in addition to the one in Detroit in the next three years.

View a PDF of the rule

Also See:

USPTO to Implement Inventor’s Oath or Declaration Provisions of the Leahy-Smith America Invents Act

U.S. Patent and Trademark Office Seeks Public Input on Proposed Fees

USPTO to Test New Post Final Rejection Option

USPTO Expands Patent Law School Clinic Certification Pilot Program

USPTO Launches Small Business Innovation Research Pilot Program

Companies Mentioned

Patent Law

The following companies are mentioned in Patent Law Updates:

Boston Scientific Corp.

Microsoft Corp.

Samsung Electronics America, Inc.

Cordis Corp.

Boston Scientific Scimed, Inc.

U.S. Patent and Trademark Office

Stryker Corp.

Acumed, LLC

Quanta Computer, Inc.

Sanyo North America Corp.

LG Electronics, Inc.

Smith & Nephew, Inc.

Cohesive Technologies, Inc.

Waters Corp.

Swisa, Inc.

Egyptian Goddess, Inc.

Motorola, Inc.

Dror Swisa

Johnson & Johnson, Inc.

Target Corp.

Sears Holding Corp.

Prometheus Laboratories, Inc.

Mayo Collaborative Services d.b.a. Mayo Medical Laboratories

Kohl’s Department Stores, Inc.

K-Mart Corp.

J.C. Penney Company, Inc.

Audiovox Communications Corp.

Glamourmom LLC

McKesson Information Solutions, Inc.

Federated Department Stores

Bridge Medical, Inc.

Elizabeth Lange LLC d.b.a. Liz Lange Maternity

United States Patent and Trademark Office

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, plc.)

SmithKline Beecham PLC

HT Window Fashion Corp.

SmithKline Beecham Corp. d.b.a GlaxoSmithKline

Scimed Life Systems Inc.

Ortho-McNeil Pharmaceutical, Inc.

Glaxo Group Limited d.b.a. GlaxoSmithKline

Mylan Pharmaceutical, Inc.

Ranbaxy, Inc.

Mylan Laboratories, Inc.

Nokia, Inc.

Teva Pharmaceuticals USA, Inc.

Stryker Sales Corp.

Stryker Orthopaedics

Howmedica Osteonics Corp.

Teva Pharmaceuticals Industries, Ltd.

Abbot Laboratories

Additional Resources

Patent Law

Further Reading in Patent Law

Other Recent Summaries

Recent Expert Legal Commentaries